Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $290.0000 (-6.45%) ($290.0000 - $320.0000) on Wed. Dec. 29, 2010. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 6.27% (three month average) | | RSI | 62 | | Latest Price | $290.0000(-6.45%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | CAPR declines -1% a day on average for past five trading days. | | Weekly Trend | CAPR advances 12.7% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | | Factors Impacting CAPR price | CAPR will decline at least -3.135% in a week (0% probabilities).
REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -3.135% (StdDev 6.27%) | | Hourly BBV | 0 () | | Intraday Trend | -9.4% | | | | | |
|
| 5 Day Moving Average | $306.81(-5.48%) | | 10 Day Moving Average | $279.35(3.81%) | | 20 Day Moving Average | $264.22(9.76%) | | To recent high | -22.7% | | To recent low | 31.8% | | Market Cap | $5.712b | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |